Pathogen inactivation methods to prevent transfusion-transmissible arboviruses: A systematic review and meta-analysis (2023)

Peer-Reviewed Study · Giménez-Richarte Á; Ortiz de Salazar MI; Giménez-Richarte MP; Larrea L; Arbona C; Marco P; Ramos-Rincón JM · March 14, 2023

Giménez-Richarte Á et al., 2023-03-14: Systematic review and meta-analysis (59 publications, 17 arboviruses) comparing pathogen inactivation methods including methylene blue plus visible light/THERAFLEX; 13 arboviruses reach at least 4-log reduction with at least one method.

For 13 arboviruses, including Chikungunya virus, Dengue virus, West Nile virus and Zika virus, at least one of the methods achieves adequate or optimal log reduction of viral load-mean LRF ≥4.

Abstract

Giménez-Richarte Á et al., 2023-03-14: Systematic review and meta-analysis (59 publications, 17 arboviruses) comparing pathogen inactivation methods including methylene blue plus visible light/THERAFLEX; 13 arboviruses reach at least 4-log reduction with at least one method. Study type: systematic review and meta-analysis, PROSPERO CRD42022312061, MEDLINE and Embase. 59 publications, 17 arboviruses; NR for subjects (laboratory studies). Countries: international. Comparator: other inactivation methods (amotosalen/UVA, riboflavin/UV, solvent-detergent, amustaline, PEN110) and untreated controls. Funding/COI not stated in retrieved abstract record. Useful because it ranks MB/light against the alternatives rather than in isolation. Study type: review.